The drug discovery informatics market is rapidly advancing, driven by the growing need for personalized medicine, AI integration, and cloud-based solutions. With a projected CAGR of 11.2% from 2025 to 2034, the market is set to expand significantly as pharmaceutical R&D and data-driven drug development gain momentum.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Drug Discovery Informatics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Drug Discovery Informatics Market, by Service
8.1.1. Sequence Analysis Platform
8.1.1.1. Market Revenue and Forecast
8.1.2. Molecular Modeling
8.1.2.1. Market Revenue and Forecast
8.1.3. Clinical Trial Data Management
8.1.3.1. Market Revenue and Forecast
8.1.4. Docking
8.1.4.1. Market Revenue and Forecast
9.1. Drug Discovery Informatics Market, by End-User
9.1.1. Pharmaceutical and Biotechnological Companies
9.1.1.1. Market Revenue and Forecast
9.1.2. Contract Research Organization (CRO)
9.1.2.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Service
10.1.2. Market Revenue and Forecast, by End-User
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Service
10.1.3.2. Market Revenue and Forecast, by End-User
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Service
10.1.4.2. Market Revenue and Forecast, by End-User
10.2. Europe
10.2.1. Market Revenue and Forecast, by Service
10.2.2. Market Revenue and Forecast, by End-User
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Service
10.2.3.2. Market Revenue and Forecast, by End-User
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Service
10.2.4.2. Market Revenue and Forecast, by End-User
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Service
10.2.5.2. Market Revenue and Forecast, by End-User
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Service
10.2.6.2. Market Revenue and Forecast, by End-User
10.3. APAC
10.3.1. Market Revenue and Forecast, by Service
10.3.2. Market Revenue and Forecast, by End-User
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Service
10.3.3.2. Market Revenue and Forecast, by End-User
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Service
10.3.4.2. Market Revenue and Forecast, by End-User
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Service
10.3.5.2. Market Revenue and Forecast, by End-User
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Service
10.3.6.2. Market Revenue and Forecast, by End-User
10.4. MEA
10.4.1. Market Revenue and Forecast, by Service
10.4.2. Market Revenue and Forecast, by End-User
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Service
10.4.3.2. Market Revenue and Forecast, by End-User
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Service
10.4.4.2. Market Revenue and Forecast, by End-User
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Service
10.4.5.2. Market Revenue and Forecast, by End-User
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Service
10.4.6.2. Market Revenue and Forecast, by End-User
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Service
10.5.2. Market Revenue and Forecast, by End-User
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Service
10.5.3.2. Market Revenue and Forecast, by End-User
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Service
10.5.4.2. Market Revenue and Forecast, by End-User
11.1. Collaborative Drug Discovery, Inc. Abbott
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Eurofins DiscoverX Products
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Jubliant Biosys
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Selvita
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Novo Informatics Pvt. Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. ChemAxon Ltd.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Albany Molecular Research Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Certara
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Boehringer Ingelheim International GmbH
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Infosys Ltd.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description